MedTrace Logo

Cerebrospinal Fluid Gravity Correlation Analysis

NCT05644535 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2022-12-09

No results posted yet for this study

Summary

The purpose of this study was to measure cerebrospinal fluid density in aged patients and to see if there was a correlation between these factors and cerebrospinal fluid density by using the electronic medical record system to understand the patient's gender, blood glucose, blood biochemical electrolytes and blood levels.

Conditions

  • Specific Gravity
  • Cerebrospinal Fluid

Interventions

DIAGNOSTIC_TEST

Cerebrospinal fluid densitometry

After obtaining the patient's cerebrospinal fluid specimen, the actual mass of the cerebrospinal fluid was measured by pipetting 1000 μL of cerebrospinal fluid specimen on an analytical balance using a pipette gun, and all specimens were measured three times and the average of the three times was taken as the final mass of 1000 μL of that specimen. After the mass measurement, the residual cerebrospinal fluid was disposed of as medical waste. The density of each specimen was obtained according to the density to mass conversion formula ρ=m/v.

DIAGNOSTIC_TEST

blood routine examination

After obtaining the patient's blood specimens, they were sent to the laboratory for blood routine examination.

DIAGNOSTIC_TEST

Blood electrolyte examination

After obtaining the patient's blood specimens, they were sent to the laboratory for blood electrolyte examination.

Sponsors & Collaborators

  • First People's Hospital of Chenzhou

    lead OTHER

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-01
Primary Completion
2023-05-31
Completion
2023-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05644535 on ClinicalTrials.gov